Pharmaco-metabolomics
Pharmaco-metabolomics used to determine the metabolic biomarkers that could potentially predict different responses of clinical drugs by identifying differential metabolites at baseline and correlating their variations with the therapeutic outcomes. Presently, Pharmaco-metabolomics remains in its infancy because most pharmaco-metabolomics studies are merely focused on revealing the correlation between baseline metabotypes which are influenced by factors like-gut, ages, drug intake and diets microbiota with drug responses or disease susceptibility to review and decrease the metabolic bases.
Related Conference of Pharmaco-metabolomics
October 13-14, 2025
17th International Conference on Tissue Science and Regenerative Medicine
Rome, Italy
Pharmaco-metabolomics Conference Speakers
Recommended Sessions
- Approaches in Cancer Metabolomics
- Approaches in Metabolomics
- Cancer genomics
- Clinical Metabolomics
- Computational Methodologies
- Genomics
- Lipidomics
- Mass Spectroscopy (Ms) based Metabolomics
- Metabolic Modelling and Synthetic Biology
- Metabolomics
- Metabolomics in field of Paediatric Medicine
- Metabolomics in Metabolic Engineering
- Metabolomics in Systems Biology
- Metabolomics in various Diseases
- NMR-based Metabolomics
- Nutritional Metabolomics
- Pharmaco-metabolomics
- Plant and Environmental Metabolomics
- Protein Expression and Analysis
- Systems Biology